Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel
OTCMKTS:EKTAY

Elekta Q4 2024 Earnings Report

Elekta logo
$5.09 -0.04 (-0.78%)
As of 10/2/2026 03:38 PM Eastern
ProfileEarnings HistoryForecast

Elekta EPS Results

Actual EPS
$0.11
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elekta Revenue Results

Actual Revenue
$475.78 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elekta Announcement Details

Quarter
Q4 2024
Date
6/5/2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Elekta's next earnings date is estimated for Wednesday, November 25, 2026, based on past reporting schedules.

Conference Call Resources

Elekta Earnings Headlines

Elekta data support expanded use of Gamma Knife for multiple brain metastases
September 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-data-support-expanded-use-of-gamma-knife-for-multiple-brain-metastases?utm_source=marketbeat.com&utm_medium=referral
Elekta’s Unity Data Boost Pancreatic Cancer Outcomes as Unity Pro Rolls Out
September 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elektas-unity-data-boost-pancreatic-cancer-outcomes-as-unity-pro-rolls-out?utm_source=marketbeat.com&utm_medium=referral
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
October 3 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Elekta Broadens Adaptive Radiotherapy Portfolio Across Modalities
September 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-broadens-adaptive-radiotherapy-portfolio-across-modalities?utm_source=marketbeat.com&utm_medium=referral
Insulet (NASDAQ:PODD) & Elekta (OTCMKTS:EKTAY) Critical Comparison
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31055432
Elekta AGM Approves Dividend, Board Mandates and New Incentive Plan
September 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-agm-approves-dividend-board-mandates-and-new-incentive-plan?utm_source=marketbeat.com&utm_medium=referral
See More Elekta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email.

About Elekta

Elekta (OTCMKTS:EKTAY) is a Sweden-based medical technology company that develops and supplies equipment, software and related services for radiation oncology and neurosurgery. Its technologies are used by hospitals and cancer treatment centers to plan and deliver precision radiation treatments for patients with cancer and neurological disorders.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, brachytherapy solutions, treatment-planning and oncology information software, and magnetic resonance-guided radiation therapy technology. Its products include the Leksell Gamma Knife platform, Versa HD and Harmony linear accelerators, Elekta Unity MR-linac systems, and MOSAIQ oncology software.

Elekta was founded in 1972 by Swedish neurosurgeon and inventor Lars Leksell. The company serves healthcare providers internationally, with operations, customers and service activities across Europe, the Americas, Asia and other global markets. Gustaf Salford serves as Elekta’s president and chief executive officer.

View Elekta Profile
Earnings Tools